2016
DOI: 10.5812/archcid.36787
|View full text |Cite
|
Sign up to set email alerts
|

Genotyping of Clinical Streptococcus agalactiae Strains Based on Molecular Serotype of Capsular (cps) Gene Cluster Sequences Using Polymerase Chain Reaction

Abstract: Background: Group B Streptococcus (GBS) is major cause of serious life threatening infections including sepsis, pneumonia and meningitis in neonates as well as in pregnant women. Capsular polysaccharide typing is significant and essential for epidemiological studies of GBS. Objectives:The aim of the current study was to differentiate genotypes of GBS clinical isolates based on the polymerase chain reaction (PCR) to acquire information about distribution of GBS types in Hamedan, Iran. Methods: In this experimen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
8
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(10 citation statements)
references
References 25 publications
1
8
1
Order By: Relevance
“…Streptococcus agalactiae is detected as a vaginal and intestinal microbiota in women causing concerning health associated problems in newborns (do Nascimento et al 2019 ; Arabestani et al 2017 ; Khademi and Sahebkar 2020 ). This bacterium is the cause of the early onset disease and late onset disease in neonates delivered by mothers with risk factors, including the delivery before the 37th week of pregnancy, the membrane rupture at least 18 h before delivery, an unexplained fever (≥ 38 °C) during delivery, and a S. agalactiae caused a history of invasive disease in a previous infant or urinary tract infection in the current pregnancy (Genovese et al 2020 ; Khademi and Sahebkar 2020 ).…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations
“…Streptococcus agalactiae is detected as a vaginal and intestinal microbiota in women causing concerning health associated problems in newborns (do Nascimento et al 2019 ; Arabestani et al 2017 ; Khademi and Sahebkar 2020 ). This bacterium is the cause of the early onset disease and late onset disease in neonates delivered by mothers with risk factors, including the delivery before the 37th week of pregnancy, the membrane rupture at least 18 h before delivery, an unexplained fever (≥ 38 °C) during delivery, and a S. agalactiae caused a history of invasive disease in a previous infant or urinary tract infection in the current pregnancy (Genovese et al 2020 ; Khademi and Sahebkar 2020 ).…”
Section: Introductionmentioning
confidence: 99%
“…S. agalactiae is classified based on capsular polysaccharide antigens, and ten serotypes are currently determined, including Ia, Ib, and II-IX (Botelho et al 2018 ; Haimbodi et al 2021 ; Huang et al 2019 ). Serotypes Ia, II, III, and V are the more prevalent S. agalactiae in USA and Europe, causing human diseases (Arabestani et al 2017 ). Also, serotypes III, Ia, Ib, II, and V are the most prevalent S. agalactiae in neonatal disease, while type III has been associated with severe infections (Arabestani et al 2017 ; Barros et al 2023 ).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Based on the capsular polysaccharide (CPS) antigens, GBS are classified into 13 serotypes. Among 13 variants, 9 variants, Ia, Ib, II, III, IV, V, VI, VII, and VIII, are considered as clinically important [ 6 ]. The capsular polysaccharides of GBS isolates are the important virulence factors with antiphagocytic purposes and therefore are used as the key components of developing new multivalent GBS vaccines [ 4 ].…”
Section: Introductionmentioning
confidence: 99%